@FierceMedDev: ICYMI yesterday: Startup wins $9.4M Series A to back speedy handheld vital sign scanner. Article | Follow @FierceMedDev
@VarunSaxena2: Medtronic to buy Twelve for $408M+, joining Abbott and Edwards on the transcatheter mitral valve bandwagon. Report | Follow @VarunSaxena2
@EmilyWFierce: Readers weighed in on who $AGN should buy next. Find out who emerged the winner. More from FiercePharma | Follow @EmilyWFierce
> A former employee of medical device company PenRad Technologies is alleged to have stolen almost $1 million from the company. Story
> Greatbatch ($GB) has extended a partnership with WiTricity to provide wireless charging for its medical devices. More
> Masimo ($MASI) has partnered with St. Joseph Hoag Health to open a wellness facility in its Irvine, CA headquarters. More
Biotech News
@FierceBiotech: TSRI researchers spotlight a hidden cause of antibiotics resistance. Story from FierceBiotechResearch | Follow @FierceBiotech
@JohnCFierce: Immatics, MD Anderson partner on a $60M immuno-oncology T-cell spinout. News | Follow @JohnCFierce
> Pharma giants line up behind an $83M crossover round for IPO-bound Merus. News
> Sarepta snags priority review status to keep pace with BioMarin in DMD race. Article
> Jeb Bush's unfulfilled promise shows the perils of building blockbuster biotech clusters. Story
Pharma News
@FiercePharma: UPDATED: With vote approaching, Perrigo chief slams Mylan's 'troubling' values. Story | Follow @FiercePharma
@CarlyHFierce: ICYMI yesterday: Shire rejigs manufacturing deal to step up Cinryze production. Story | Follow @CarlyHFierce
> Eli Lilly pops the bubbly on U.S. Alimta patent victory. More
> U.S. patent office puts new Copaxone's IP shield under the lens. Article
Biotech Research News
> New method uses coated gold nanorods to treat pain. Item
> UCSF cardiology chief builds a case for two new targets for heart drugs. More
> UC Berkeley team says brown fat implants may effectively tackle obesity. Report
> TSRI researchers spotlight a hidden cause of antibiotics resistance. Article
> MSK: 'This is what the future of precision medicine looks like.' Story
Diagnostics News
> Sequenom strikes liquid biopsy research deal with UC San Diego Moores. Item
> Roche shops around for sequencing tech with Lumora buy. More
> Illumina makes moves in China with Burning Rock cancer Dx deal. Report
> Roche's M&A party rages on with Kapa Biosystems deal. Story
> Guardant Health teams with Flatiron for liquid biopsy-based drug development platform. Article
Pharma Marketing News
> Novo pulls blockbuster diabetes med Victoza off the Type 1 track. Report
> Eli Lilly slaps down Teva's challenge to Alimta exclusivity. Item
> AstraZeneca uses snails and overstuffed luggage to push OIC awareness--and its branded solution. Article
> Boehringer Ingelheim partners with telenovela for diabetes storyline. News
> Can Sprout's Addyi shrug off serious side effects? These blockbusters did. Story